A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.
A team of researchers have reported T cells survive a tumor’s anoxic environment and become more effective at killing cancer cells by exploiting HIF-1a and when they have access to growth factor VEGF-A.
Find out about IMPACT, a partnership between Anthony Nolan, Leuka, NHS Blood and Transplant and the University of Birmingham (UK), which aims to deliver the UK’s first large-scale clinical trials program in this exclusive blog piece.
Researchers have demonstrated for the first time, in mice, that carbon nanotubes may pose a similar carcinogenic effect as asbestos.
A recent study presented at The Liver Meeting® held by the American Association for the Study of Liver Diseases, demonstrates that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B related liver cancer.
Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period
Among other criteria, in this research article from Future Science OA, the authors validated the Gynecological Cancer Intergroup CA125 progression criteria in an ovarian cancer population regarding sensitivity, specificity, positive predictive value and negative predictive value.
A novel study has demonstrated how the Warburg effect, a phenomenon in which cancer cells rapidly breaks down sugars, stimulates tumor growth
A preliminary study for the assessment of PD-L1 and PD-L2 on circulating tumor cells by microfluidic-based chipcytometry
Discover preliminary data for a new assay workflow to detect the presence of PD-L1 and PD-L2 on the surface of tumor cells that have broken away from the tumor and entered the blood in this research article from Future Science OA.
Researchers have discovered that lung cancer cells are able to utilize lactate as an energy source to facilitate growing. This finding challenges the previous understanding of cancer metabolism and may have implications for future cancer research.